Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001047469-18-005228
Filing Date
2018-07-27
Accepted
2018-07-27 06:25:05
Documents
113
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 6-K a2236267z6-k.htm 6-K 16267
2 EX-99.1 a2236267zex-99_1.htm EX-99.1 1953692
9 G73016.JPG g73016.jpg GRAPHIC 8540
  Complete submission text file 0001047469-18-005228.txt   16168251

Data Files

Seq Description Document Type Size
3 EX-101.INS hcm-20180630.xml EX-101.INS 5391706
4 EX-101.SCH hcm-20180630.xsd EX-101.SCH 97937
5 EX-101.CAL hcm-20180630_cal.xml EX-101.CAL 117808
6 EX-101.LAB hcm-20180630_lab.xml EX-101.LAB 758731
7 EX-101.PRE hcm-20180630_pre.xml EX-101.PRE 629376
8 EX-101.DEF hcm-20180630_def.xml EX-101.DEF 345726
Mailing Address 22ND FLOOR HUTCHISON HOUSE 10 HARCOURT ROAD HONG KONG K3 00000
Business Address 22ND FLOOR HUTCHISON HOUSE 10 HARCOURT ROAD HONG KONG K3 00000 852-2121-3888
Hutchison China MediTech Ltd (Filer) CIK: 0001648257 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-37710 | Film No.: 18973182
SIC: 2834 Pharmaceutical Preparations